Abstract
In the ASTRUM-007 randomized double-blind phase III study, Song etal.1 showed that the combination of PD-1 inhibitors with first-line fluoropyrimidine and platinum-based chemotherapy improves outcomes in PD-L1-overexpressing esophageal squamous cell carcinomas.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have